NxStage Voluntary Sak Recall
Higher levels of endotoxin than NxStage tolerates were found in less than 1% of affected sak lots, so they notified patients who had those lots and issued a voluntary recall. An FDA recall was not required.
Read the full article » | Posted 02/15/2018
Related Articles
- Fresenius a “Top Performer” in its Sector Posted 04/12/2018
- New Baxter PD Cycler in Korea Posted 04/12/2018
- NxStage Shared its Knowledge at the ADC Posted 04/12/2018
- Davita Educational Tools You Might Not Be Aware Of Posted 03/16/2018